Internal Medicine, Nephrology · Las Vegas, NV
NPI
1689850695
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2425 N Lamb Blvd Ste 120
Las Vegas, NV, 89115
Phone (702) 851-7766
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,368
61 services
Medicare patients, 2024
19
Average age 57
Drug cost, 2024
$134K
1,803 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Rui Yu prescribed most often to Medicare patients was Calcitriol, with 226 prescriptions and refills. In total Rui Yu wrote 1,803 Medicare prescriptions that cost $134K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Calcitriol Generic | 226 | 671 | 83 | $3,778 |
| Losartan Potassium Generic | 155 | 513 | 60 | $2,434 |
| Furosemide Generic | 135 | 419 | 54 | $2,337 |
| Amlodipine Besylate Generic | 112 | 359 | 50 | $1,497 |
| Jardiance Empagliflozin | 95 | 271 | 35 | $59K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 92 | 270 | 32 | $2,616 |
| Lisinopril Generic | 84 | 278 | 40 | $1,324 |
| Metoprolol Tartrate Generic | 83 | 271 | 35 | $952 |
| Sevelamer Carbonate Generic | 65 | 201 | 33 | $20K |
| Atorvastatin Calcium Generic | 63 | 210 | 31 | $722 |
| Hydralazine Hcl Generic | 61 | 202 | 32 | $1,871 |
| Allopurinol Generic | 54 | 172 | 17 | $460 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 48 | 48 | 12 | $927 |
| Potassium Chloride Generic | 48 | 138 | 20 | $1,761 |
| Calcium Acetate Generic | 40 | 125 | 17 | $5,619 |
Brand drugs: - claims; generic drugs: 1,698 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rui Yu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.